Clear0123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100SPSPLCLVSCSVREIREISISEIVISVEMEMSESEV1F2F3G5FWSCESFMCNTMLGSGUSCUSCISCEMC05101520253035404550556065707580859095100

IFA Index Portfolio 100 IFA Index Portfolio 35

Moderately Conservative: Suitable for investors who have 6 years before needing approximately 20% of their investments and are willing to accept a moderately conservative degree of risk to achieve portfolio growth potential.

The data provided in charts referring to IFA Index Portfolios is hypothetical back-tested performance and is not actual client performance. Performance data for the IFA Index Portfolios is shown net of IFA's highest advisory fee and the underlying mutual fund expenses. IFA Indexes when shown individually do not reflect a deduction of advisory fees. None of the data reflects trading costs or taxes, which would have lowered performance by these costs. See more important disclosures at ifabt.com.

Socially Responsible Index Portfolio 35 Allocation

General Asset ClassAllocationSpecific Asset ClassFund NameTickerHoldings*Weight Avg Market (millions)*Price to Book*
21.00% US Social Core Equity21.00%US Social Core EquityDFA US Social Core Equity 2DFUEX2,108$84,474.163.24
3.50% Real Estate3.50%Global Real EstateDFA Global Real Estate SecuritiesDFGEX144$17,725.281.64
7.00% International7.00%International Social CoreDFA International Social Core EquityDSCLX4,037$11,270.611.39
3.50% Emerging Markets3.50%Emerging Markets Social CoreDFA Emerging Markets Social Core EquityDFESX6,154$11,386.191.41
65.00% Fixed Income65.00%Social Fixed IncomeDFA Social Fixed IncomeDSFIX441n/an/a
*Updated as of 6/2/2025

Explanation of Socially Responsible Index Portfolios

The Stock Funds Included in the Socially Responsible Index Portfolios are Screened to Exclude Companies that:

  • Directly participate in abortions
  • Own or operate acute-care hospitals or surgical centers
  • Engage in the development or manufacture of abortifacients.
  • Derive identifiable revenues from the development or manufacture of contraceptives.
  • Conduct stem cell research with cells derived from human embryos or fetal tissue, use fetal cell lines in the development of vaccines and other biologics such as therapeutic proteins and gene therapy products, or develop products for scientific research specifically on embryonic or fetal stem cells, such as technology that isolates or regulates the growth and proliferation of stem cells.
  • Derive 10% (or more) of their total business revenue from the rental, sale, distribution or production of pornographic materials or the ownership or operation of adult entertainment establishment.
  • Derive 10% (or more) of revenue from the manufacture of alcoholic beverages, the supply of raw materials and other products necessary for the production of alcoholic beverages or the distribution of alcoholic beverages.
  • Have had major recent controversies relating to child labor infractions in the US or abroad.
  • Derive 10% (or more) of revenue from the production of goods used exclusively for gambling, such as slot machines; ownership and/or operation of casinos, racetracks, bingo parlors, or other betting establishments; or the provision of services in casinos that are fundamental to gambling operations, such as gambling technology.
  • Are involved in the production of anti-personnel landmines, anti-vehicle landmines, or the essential components of these products.
  • Derive 10% (or more) of revenue from the production and/or sale of military weapons or weapons systems; customized components for military weapons or weapons systems; or weapons of mass destruction, including nuclear weapons, nuclear weapons systems, and customized components thereof.
  • Conduct business in Sudan, including those that own assets in, have employees/facilities in, obtain goods/services from, or have distribution agreements in Sudan; that issue credits or loans to companies domiciled in Sudan; or provide goods/services to, or purchase goods or commercial paper issued by, the government of Sudan.
  • Derive at least 10% of revenue from the manufacture of tobacco products, production of raw materials and other products necessary for the production of tobacco products, or the distribution of tobacco products.

For more information see Socially Responsible Investing at dimensional.com.